Haemonetics

HAE · NYSE

$118.21−$0.52 (−0.44%)TodayMarket closed ·
Prev close $118.73

About HAE

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. The company is headquartered in Boston, Massachusetts and currently employs 3,023 full-time employees. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). The company also offers solutions for structural heart and endovascular procedures.

Employees
3,023
Headquarters
Boston, Massachusetts
Listed
Oct 17, 1979
Sector
Health Care
Industry
Health Care Equipment & Supplies

Leadership

Haemonetics executives
NameTitleSince
Ellen Zane——
Christopher Simon—2016
James D'Arecca——
Frank Chan——
Laurie Miller——
Michelle Basil——
Roy Galvin——
Olga Guyette——
Robert Abernathy——
Diane Bryant——
Michael Coyle——
Charles Dockendorff——
Lloyd Johnson——
Mark Kroll——
Claire Pomeroy——

Revenue by product and region

Fiscal year ended Mar 29, 2025: $1.36B total revenue

By product

  • Hospital$564.27M41.5%
  • Plasma$535.43M39.3%
  • Blood Center$261.12M19.2%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Haemonetics suppliers and customers
CompanyRelationshipCorrelation
Cerus Corporation CERSCustomer0.69
JMS Co.,Ltd.Supplier0.65
GVS S.p.A. GVS.MISupplier0.40
Sanmina Corporation SANMSupplier-0.48
Pfizer Inc. PFESupplier-0.70
Danaher Corporation DHRSupplier-0.72
CSL Limited CMXHFCustomer—
Grifols, S.A. GIFLFCustomer—
Winnergy Medical Public Company Limited WINMED.BKCustomer—

Similar companies

Companies in the same industry as Haemonetics

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.